PlainRecalls
FDA Drug Critical Class I Ongoing

Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08

Reported: June 19, 2024 Initiated: May 28, 2024 #D-0553-2024

Product Description

Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08

Reason for Recall

Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Details

Recalling Firm
Sagent Pharmaceuticals
Units Affected
762 vials
Distribution
Nationwide within the USA.
Location
Schaumburg, IL

Frequently Asked Questions

What product was recalled?
Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08. Recalled by Sagent Pharmaceuticals. Units affected: 762 vials.
Why was this product recalled?
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 19, 2024. Severity: Critical. Recall number: D-0553-2024.